738 related articles for article (PubMed ID: 29109032)
1. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
[TBL] [Abstract][Full Text] [Related]
2. MG53 and disordered metabolism in striated muscle.
Hu X; Xiao RP
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1984-1990. PubMed ID: 29017896
[TBL] [Abstract][Full Text] [Related]
3. The role of NADPH oxidases in diabetic cardiomyopathy.
Hansen SS; Aasum E; Hafstad AD
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1908-1913. PubMed ID: 28754449
[TBL] [Abstract][Full Text] [Related]
4. Human embryonic stem cell-derived cardiomyocytes as an in vitro model to study cardiac insulin resistance.
Geraets IME; Chanda D; van Tienen FHJ; van den Wijngaard A; Kamps R; Neumann D; Liu Y; Glatz JFC; Luiken JJFP; Nabben M
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1960-1967. PubMed ID: 29277329
[TBL] [Abstract][Full Text] [Related]
5. Protecting the heart through MK2 modulation, toward a role in diabetic cardiomyopathy and lipid metabolism.
Ruiz M; Coderre L; Allen BG; Des Rosiers C
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1914-1922. PubMed ID: 28735097
[TBL] [Abstract][Full Text] [Related]
6. Amylin and diabetic cardiomyopathy - amylin-induced sarcolemmal Ca
Liu M; Hoskins A; Verma N; Bers DM; Despa S; Despa F
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1923-1930. PubMed ID: 29066284
[TBL] [Abstract][Full Text] [Related]
7. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cardiac energetics by non-invasive
Abdurrachim D; Prompers JJ
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1939-1948. PubMed ID: 29175056
[TBL] [Abstract][Full Text] [Related]
9. Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.
Guleria RS; Singh AB; Nizamutdinova IT; Souslova T; Mohammad AA; Kendall JA; Baker KM; Pan J
J Mol Cell Cardiol; 2013 Apr; 57():106-18. PubMed ID: 23395853
[TBL] [Abstract][Full Text] [Related]
10. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Dec; 1862(12):2211-2220. PubMed ID: 27479696
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
12. Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy.
Zhang L; Ding WY; Wang ZH; Tang MX; Wang F; Li Y; Zhong M; Zhang Y; Zhang W
J Transl Med; 2016 Apr; 14(1):109. PubMed ID: 27121077
[TBL] [Abstract][Full Text] [Related]
13. Lipid droplet proteins and metabolic diseases.
Xu S; Zhang X; Liu P
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1968-1983. PubMed ID: 28739173
[TBL] [Abstract][Full Text] [Related]
14. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
15. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms.
Mahmoud AM
Adv Exp Med Biol; 2017; 999():207-230. PubMed ID: 29022265
[TBL] [Abstract][Full Text] [Related]
16. The impact of FOXO-1 to cardiac pathology in diabetes mellitus and diabetes-related metabolic abnormalities.
Chistiakov DA; Orekhov AN; Bobryshev YV
Int J Cardiol; 2017 Oct; 245():236-244. PubMed ID: 28781146
[TBL] [Abstract][Full Text] [Related]
17. Successful metabolic adaptations leading to the prevention of high fat diet-induced murine cardiac remodeling.
Roberts NW; González-Vega M; Berhanu TK; Mull A; García J; Heydemann A
Cardiovasc Diabetol; 2015 Sep; 14():127. PubMed ID: 26408147
[TBL] [Abstract][Full Text] [Related]
18. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
[TBL] [Abstract][Full Text] [Related]
19. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
[TBL] [Abstract][Full Text] [Related]
20. Lipotoxicity in obesity and diabetes-related cardiac dysfunction.
Zlobine I; Gopal K; Ussher JR
Biochim Biophys Acta; 2016 Oct; 1861(10):1555-68. PubMed ID: 26899197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
